We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Leptin, appetite and puberty

A Cambridge Clinical Research Facility success story.

Researchers conducted the first trials of treatment with leptin (a recently discovered hormone that controls appetite) in patients with hereditary leptin deficiency.

In addition to dramatic effects on body weight and appetite, these studies showed that leptin also has a role in regulating human development in puberty, and immune function.

The paper 'Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency' was published in 'The New England Journal of Medicine' on 16 September 1999 (volume 341: pp 879-884).

Find out more about the Cambridge Clinical Research Facility.

Image credit: Fiona Pragoff

Share |
Home  >  Funding  >  Biomedical science  >  Funded projects  >  Major initiatives  >  Clinical Research Facilities  > Leptin, appetite and puberty
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888